Sign In

Matthew Tindall

CEO at Flightpath Biosciences

Matthew Tindall is the Co-Founder and Chief Executive Officer of Flightpath Biosciences, Inc., a clinical-stage life sciences company focused on developing therapeutics for infectious diseases, particularly Lyme disease. He has been in this role since the company's inception in 2019. Under his leadership, Flightpath has initiated significant clinical trials, including the testing of FP-100, a novel narrow-spectrum antibiotic aimed at treating Lyme disease and other related conditions.124

Background and Experience

Tindall holds an MBA with a focus on Finance and Entrepreneurship and a Bachelor's degree in Human Physiology. His professional journey includes various high-level positions in the healthcare sector:

  • Founder & CEO at Flightpath Biosciences (2019 - Present)
  • Advisor at Parallel Health (2022 - Present)
  • Co-Founder of Kodikaz Therapeutic Solutions, Inc. (2017 - Present)
  • CEO at Fabric Genomics (2016 - 2017)
  • General Manager at IQVIA (2013 - 2016)
  • VP of Marketing at Digitas Health (2010 - 2012)
  • Previous roles include business development and sales positions at Genzyme Corporation and Eli Lilly.135

Achievements

Tindall's leadership has been pivotal in advancing Flightpath's mission to address significant unmet medical needs in Lyme disease treatment. The company recently began human clinical testing of FP-100, which is designed to selectively target Borrelia burgdorferi, the bacterium responsible for Lyme disease, while minimizing disruption to the gut microbiome.24 This innovative approach represents a potential breakthrough in antibiotic development and treatment strategies for infectious diseases.

In addition to his work with Flightpath, Tindall has been involved with other health initiatives, serving as an advisor for organizations like Courage Health and contributing to various therapeutic solutions within the biotech space.13

Highlights

Jun 12 · linkedin

Perspective.

Every once in a while, I find it useful to think about my personal and professional aspirations through a new lens. With so much marketing, partnering, business, monetization and hustle in my world…it’s useful to lean back and appreciate what “is”.

This quirky series of vignettes on Instagram is refreshingly positive and optimistic. Take a look.

May 21 · linkedin

A personal musing. Forgive me.

As a young man, from a rural farm town in the middle of the corn fields in mid-Michigan, I dreamed of doing something remarkable with my “one life”. Making some difference. Something bigger than where I was at the time.

After @Corunna high school, I left, went to Texas, attended UTexas Austin. Pursued an MBA and on graduation day in Austin, I remember telling my parents privately in front of the fountain near the business school that “now, everything is going to be alright, I’m on my path” and “someday I’ll be on the cover of Time magazine”. The latter was just a confidence booster for me, a throw away, almost.

Now, at 52, that long held vision has come true. Sort of. For Lyme disease patients - we are making a difference. Even if this means we are putting patients “on the radar”.

Now, our perpetually understated and brilliant Cofounding Scientist Kim Lewis didn’t exactly talk about how much potential our “new drug” (FP-100) has, we know that it’s the furthest advanced drug prospectively developed for treatment of Lyme disease. And that it kills the bacteria that drives syphilis, gum disease and some kinds of cancer to metastasize. But, I digress…

His discovery demonstrates that you can target only certain “bad bacteria” with antibiotics. Only the pathogenic ones without doing catastrophic damage to the healthy gut flora.

While that doesn’t come through in this TIME story - it should.

A win for everyone today. I have a terrific team.

Matt

Read in TIME: https://lnkd.in/evNr5Ntp

Related Questions

What inspired Matt Tindall to start Flightpath Biosciences?
How did Matt Tindall's previous roles prepare him for his current position at Flightpath Biosciences?
What are the key achievements of Matt Tindall in his career?
How does FP-100 work to treat Lyme disease?
What other diseases is FP-100 being developed to treat?
Matthew Tindall
Matthew Tindall, photo 1
Matthew Tindall, photo 2
Add to my network

Location

San Francisco Bay Area